Sci-Tech Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.

Press releases published on April 17, 2026

AGM Mobile presentará sus últimas innovaciones robustas en la Feria de Cantón 2026
Fyresite Reaches New Heights With Shopify Premier Partner Promotion
Hisense unveils 2026 RGB MiniLED TV range at FIFA Headquarters
Rocket Doctor Amends 45 Degree Agreement
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Leading Formula 1™️Technology Expert to Close Sabio Disrupt London
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Chinese Top 3 Thermal Imaging Phone Brands in 2026 Promoting Industry Standardization and Innovation
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026
TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call
TIG SOFTWARE Announces Cloud-Native Casino Game Infrastructure for Worldwide Deployment
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
4DMT Announces New Employment Inducement Grants
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

Share this page:

Sign up for:

Sci-Tech Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.